BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14976452)

  • 1. The presence and structure of circulating immune complexes in patients with prostate tumors.
    Gołda R; Wolski Z; Wyszomirska-Gołda M; Madaliński K; Michałkiewicz J
    Med Sci Monit; 2004 Mar; 10(3):CR123-7. PubMed ID: 14976452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients.
    Beneduce L; Prayer-Galetti T; Giustinian AM; Gallotta A; Betto G; Pagano F; Fassina G
    Cancer Detect Prev; 2007; 31(5):402-7. PubMed ID: 18035503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of entamoeba histolytica antigens in circulating immune complexes in sera of patients with amoebiasis.
    Sengupta K; Ghosh PK; Ganguly S; Das P; Maitra TK; Jalan KN
    J Health Popul Nutr; 2002 Sep; 20(3):215-22. PubMed ID: 12430757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes (CIC) in Hodgkin's disease. I. Levels and two-dimensional analysis.
    Nerurkar AV; Advani SH; Gothoskar BP
    Neoplasma; 1989; 36(2):199-205. PubMed ID: 2716924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliadin IgG antibodies and circulating immune complexes.
    Eisenmann A; Murr C; Fuchs D; Ledochowski M
    Scand J Gastroenterol; 2009; 44(2):168-71. PubMed ID: 18819035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of circulating immune complexes in prognostic evaluation and management of genitourinary cancer patients.
    Aziz M; Das TK; Rattan A
    Indian J Cancer; 1997 Sep; 34(3):111-20. PubMed ID: 9491672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes in tuberculosis.
    Arora A; Wali JP; Seth P; Guleria JS; Aggarwal P
    Singapore Med J; 1991 Apr; 32(2):116-8. PubMed ID: 2042070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Isolation and characterization of immune complexes associated with malignant tumors and leprosy].
    Segal-Eiras A; Croce MV; Ramos GS; Córsico B
    Medicina (B Aires); 1989; 49(2):125-30. PubMed ID: 2640480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH.
    Muecke R; Klotz T; Giedl J; Buentzel J; Kundt G; Kisters K; Prott FJ; Micke O
    Acta Oncol; 2009; 48(3):452-6. PubMed ID: 18855158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of circulating immune complexes in malignant tumours of head and neck.
    Das TK; Aziz M; Rattan A; Sherwani R
    J Indian Med Assoc; 1995 Jan; 93(1):3-7. PubMed ID: 7759908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mycobacterial antigens and antibodies in circulating immune complexes from pulmonary tuberculosis.
    Raja A; Narayanan PR; Mathew R; Prabhakar R
    J Lab Clin Med; 1995 May; 125(5):581-7. PubMed ID: 7738424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of sera from ovarian cancer patients for immune complexes.
    Witkin SS; Bongiovanni AM; Armbruster T; Birnbaum S; Caputo T
    J Clin Lab Immunol; 1984 Jun; 14(2):65-8. PubMed ID: 6748047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of plasma interleukin-8 concentration in patients with prostate cancer and benign prostate hyperplasia.
    Dehghani M; Mostafavi-Pour Z; Lotfi M; Shakeri S
    Iran J Immunol; 2009 Jun; 6(2):92-8. PubMed ID: 19561378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
    Hermani A; Hess J; De Servi B; Medunjanin S; Grobholz R; Trojan L; Angel P; Mayer D
    Clin Cancer Res; 2005 Jul; 11(14):5146-52. PubMed ID: 16033829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes in Hodgkin's disease.
    Akolkar PN; Advani SH; Gothoskar BP
    Neoplasma; 1983; 30(1):73-9. PubMed ID: 6835441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility and monitoring of breast cancer by circulating immune complexes.
    Dass TK; Aziz M; Rattan A; Tyagi SP
    Indian J Pathol Microbiol; 1992 Oct; 35(4):298-307. PubMed ID: 1344219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antibody response to Propionibacterium acnes is an independent predictor of serum prostate-specific antigen levels in biopsy-negative men.
    Shannon BA; Cohen RJ; Garrett KL
    BJU Int; 2008 Feb; 101(4):429-35. PubMed ID: 17850358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonspecificity of assaying for IgG antibody to pneumolysin in circulating immune complexes as a means to diagnose pneumococcal pneumonia.
    Musher DM; Mediwala R; Phan HM; Chen G; Baughn RE
    Clin Infect Dis; 2001 Feb; 32(4):534-8. PubMed ID: 11181114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.
    Trojan L; Bode C; Weiss C; Mayer D; Grobholz R; Alken P; Michel MS
    Eur Urol; 2006 Feb; 49(2):286-92; discussion 292. PubMed ID: 16386354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression.
    Saleh IA; Zesiewicz T; Xie Y; Sullivan KL; Miller AM; Kuzmin-Nichols N; Sanberg PR; Garbuzova-Davis S
    J Neuroimmunol; 2009 Oct; 215(1-2):96-101. PubMed ID: 19682755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.